UNSPSC 51112505: Chlorambucil

This classification denotes a nitrogen mustard compound with the molecular formula C14H19Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18D0SL7309, chemically known as p-n,n-di-(beta-chloroethyl)aminophenyl butyric acid but more generally known as chlorambucil, which bears US NIH Compound Identifier 2708. European Medicines Agency schedules Chlorambucil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06172MIG.

UNSPSC 51112505 Chlorambucil is a Commodity code that describes a specific chemotherapy pharmaceutical product, though recent state and local procurement activity under this code shows limited direct solicitation. The Texas Health and Human Services Commission issued a Request for Information in April 2026 (RFI No. HHS0017013) that touched on pharmaceutical procurement broadly—specifically direct-to-manufacturer prescription fulfillment models—but the RFI was exploratory in nature and sought vendor capabilities for managing prescription programs rather than soliciting chlorambucil itself as a line-item purchase. State health agencies and Medicaid programs typically acquire individual pharmaceutical commodities through established pharmacy benefit manager (PBM) contracts, group purchasing organization (GPO) arrangements, or state formulary agreements rather than through discrete RFPs or IFBs for single drugs. This code appears to see minimal standalone procurement activity at the state and local level, as pharmacy acquisition is usually consolidated through broader healthcare contracting vehicles.

The Texas HHS RFI represents exploratory market research into alternative pharmaceutical procurement pathways—direct contracting with manufacturers outside traditional PBM and wholesaler channels—rather than a purchase of chlorambucil itself. The RFI, posted April 3, 2026, with the same-day response deadline, sought vendor information about negotiated net pricing models and direct fulfillment capacity for self-insured employers and state employee plans. No award value, budget allocation, or formal evaluation criteria were specified. Business development professionals pursuing chlorambucil or other specialty pharmaceutical commodities in state and local markets should focus on established PBM and GPO contracting relationships, state Medicaid formulary procurement cycles, and healthcare system group purchasing agreements rather than on discrete solicitations under this specific UNSPSC code.